ALOMA ALCOBER: Open Payments
NPI 1558314153 · KISSIMMEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,273 in 123 payments from 15 companies in 2025. Trend: 2023 $3,607 · 2024 $3,174 · 2025 $3,273
Food & beverage: $3,265Education: $8
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 23 | $645 |
| Neurocrine BioSciences, Inc. | 23 | $628 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $242 |
| Otsuka America Pharmaceutical, Inc. | 9 | $237 |
| Alkermes, Inc. | 9 | $228 |
| Vanda Pharmaceuticals Inc. | 7 | $225 |
| Janssen Pharmaceuticals, Inc | 5 | $208 |
| E.R. Squibb & Sons, L.L.C. | 8 | $191 |
| Teva Pharmaceuticals USA, Inc. | 7 | $181 |
| ABBVIE INC. | 11 | $162 |
Products named: Auvelity, INGREZZA, REXULTI, CAPLYTA, SPRAVATO, FANAPT, ARISTADA, COBENFY.
Industry payments across FL — which companies pay providers there.
